In Brief
Although memory B cells sustain longterm humoral immunity, the nature of their precursors within the germinal center has remained elusive. Suan et al. demonstrate that these cells are uniquely identified by CCR6 expression in both mouse and human germinal centers, that they are the most quiescent B cells in these structures, and that they are generated within the light zone. Memory B cell precursors have a primarily low affinity for antigen but also include cells emerging from the high-affinity compartment.
INTRODUCTION
Germinal centers (GCs) form in secondary lymphoid organs of vertebrates in response to challenge with T-cell-dependent antigens. After extrafollicular and follicular interactions with cognate antigen and T helper cells, responding B cell clones can enter the GC response, where they undergo iterative cycles of proliferation, somatic hypermutation (SHM), and selection such that clones acquiring increased affinity for the eliciting antigen preferentially accumulate (Gatto and Brink, 2010; ). This process is also associated with the differentiation of memory B cells (MBCs) and plasma cells (PCs) from GC B cell precursors. MBCs and PCs are responsible for effective long-term immunity against infectious pathogens and underpin the efficacy of almost all current vaccines (Plotkin et al., 2008) . Whereas long-lived PCs exit the GC response and primarily contribute to immune protection by homing to the bone marrow and secreting high-affinity antibodies, MBCs emerge from the GC as recirculating cells that are primed to elicit rapid antibody responses upon secondary antigen challenge.
Multiple subsets of both mouse and human MBCs have been defined according to their immunoglobulin (Ig) isotype, surface phenotype, longevity, survival requirements, SHM characteristics, and functional response to antigen re-challenge (Good-Jacobson and Shlomchik, 2010; Kurosaki et al., 2015; Tangye and Tarlinton, 2009; Tarlinton, 2006) . One point of contention has centered on the precise origins of MBCs. BCL6-deficient mice produce isotype-switched, unmutated MBCs in response to a T-cell-dependent antigen (Toyama et al., 2002) , indicating a GC-independent pathway for MBC generation. Furthermore, early, isotype-switched MBCs have been shown to arise outside of the GC response and to almost invariably carry no somatic mutations (Chan et al., 2009; Kaji et al., 2012; Taylor et al., 2012) . Nevertheless, it is broadly accepted that GCs give rise to long-lived MBCs (Shlomchik and Weisel, 2012; because of the predominance of Ig-variable-region gene SHM events among MBCs (Gray, 1993; Tangye and Tarlinton, 2009 ) and the greatly reduced numbers of somatically mutated MBCs and impaired recall responses in mice and humans who are unable to form robust GCs (Good-Jacobson and Shlomchik, 2010; Shlomchik and Weisel, 2012; Tangye et al., 2012) .
The transcription factor BLIMP-1 is required during the initiation of PC differentiation and has been used extensively for investigating GC-derived PC precursors (plasmablasts) and their further differentiation into PCs (Kallies et al., 2004) . Taking advantage of this marker, we previously showed that PC differentiation in the GC is not stochastic but rather is induced only among high-affinity GC B cells, even if low-affinity cells still predominate . A similar study of MBC differentiation has been hampered by the lack of a ''master'' transcription factor or other marker that identifies B cells destined to exit the GC as MBCs. Here, we demonstrate that expression of the chemokine receptor CCR6 specifically identifies the precursors of MBCs within the GC. CCR6 + MBC precursors were found to be highly enriched in the light zone (LZ) of both mouse and human GCs, were unique within the GC in undergoing cell-cycle exit, and possessed a gene expression signature consistent with an MBC transition. SHM and antigen-binding analyses revealed that MBCs emerge predominantly from low-affinity CCR6 + B cells in the GC LZ but also develop from rarer, high-affinity CCR6 + LZ progenitors. The differentiation of MBCs and
PCs from GC B cells is therefore driven by fundamentally different stimuli that establish the distinct roles of these two GC-derived cell types in mediating long-term immunity against reinfection. (Oliver et al., 1997; Ridderstad and Tarlinton, 1998) (Victora et al., 2010) . We restricted analysis to IgG1-switched GC and MBC cells to negate any differences associated with Ig isotype expression and to ensure exclusion of naive B cells from the analysis ( Figure 1A) .
As previously noted (Bhattacharya et al., 2007; Elgueta et al., 2015) , the majority of MBCs express high levels of the chemokine receptor CCR6 ( Figure 1A ). However, despite being previously characterized as lacking surface CCR6 (Krzysiek et al., 2000; Reimer et al., 2017) , typically around 5%-10% of GC B cells were found to be CCR6 + at this point in the response (Figure 1A) . CCR6 + GC B cells were greatly enriched within the LZ compartment, where they were present at $8-fold higher frequencies than those in the DZ ( Figure 1B ). The CCR6 + LZ population expressed many cell-surface markers (CCR6, IgG1, CD38, CD31, and EBI2) at levels that were intermediate between the LZ CCR6 À and MBC populations ( Figure 1C ). This was also the case for CD23, which, among GC B cells, was expressed at its highest level on LZ CCR6 + B cells and at similarly high levels on MBCs ( Figure 1D ). Together, these observations raise the possibility that CCR6 + LZ B cells could mark the precursors of MBCs within the GC.
CCR6 + LZ B Cells Exit the Cell Cycle but Do Not Undergo Apoptosis
Whereas GC B cells undergo iterative rounds of cell division, MBCs remain quiescent unless reactivated by antigen. We reasoned, therefore, that B cells undergoing MBC differentiation within the GC should be in the process of exiting the cell cycle and progressing toward quiescence. We thus analyzed LZ CCR6 + B cells for DNA synthesis, cell size, and expression of markers associated with cellular proliferation.
To examine DNA synthesis, we exposed SRBC-immunized mice to BrdU in their drinking water for 24 or 48 hr before harvesting their spleen cells and analyzing them by flow cytometry on day 9 after SRBC challenge. As expected, the proportion of BrdU + B cells within each GC B cell subpopulation increased between 24 and 48 hr (Figures 2A and 2B ). Among these GC subpopulations, the accumulation of BrdU + cells occurred most slowly within the LZ CCR6 + compartment (Figures 2A and 2B ), indicating that this population was enriched with GC B cells exiting the cell cycle. Consistent with this, LZ CCR6 + GC B cells also exhibited lower expression of the Ki67 proliferation marker ( Figure 2C ) and smaller cell size (forward light scatter) ( Figure 2D ) than other GC B cell subpopulations. As expected, BrdU incorporation, cell allowed identification of four IgG1 + GC B cell compartments on day 9 of the response: DZ high-affinity (DZhi), DZ low-affinity (DZlo), LZ high-affinity (LZhi), and LZ low-affinity (LZlo) B cells ( Figure 3A) . Analysis of SW HEL GC responses to HEL 3X -SRBC once again revealed that 5%-10% of IgG1 + GC B cells expressed CCR6 ( Figure 3A) . As in the polyclonal response to SRBCs, CCR6 + GC B cells were primarily located in the LZ compartment. In particular, CCR6
+ GC B cells were greatly enriched in the LZlo compartment of the GC, where they were on average 7-fold more frequent than in the LZhi, DZlo, and DZhi compartments ( Figure 3B ). SW HEL -derived LZlo CCR6 + B cells expressed a range of MBC surface markers at levels that were intermediate between those of the LZlo CCR6 À and MBC populations ( Figure 3C ) and exhibited the highest levels of CD23 among all GC B cells ( Figure 3D ). In addition, these cells did not preferentially undergo apoptosis in the GC ( Figure S1A ). Thus, the CCR6 + GC B cells found in the SW HEL B cell response to HEL 3X had a phenotype identical to that observed in the polyclonal anti-SRBC response, but they also showed a resolution to LZ GC B cells that retain a mostly low affinity for the initiating antigen. Time-course analysis revealed that, both in donor SW HEL mice and endogenously in SRBC responses, an early burst of CCR6 + GC B cell production around day 7 was followed by a rapid decline of these cells and a plateau phase from day 9 onward where CCR6 + B cells composed 5%-15% of the GC LZ (Figures S1B-S1E).
CCR6 + LZ B Cells Are the Most Quiescent Cells in the GC
The ability to resolve high-and low-affinity SW HEL B cells within the LZ allowed us to characterize CCR6 + GC B cells in greater detail. To assess the relative cell-cycle activity in this population, we administered BrdU intravenously to recipient mice 9 days after transfer of SW between GC and MBC subsets in terms of both cell-surface marker expression and cell-cycle activity lead us to conclude that these cells represent the direct precursors of MBCs within the GC. We also considered the possibility that the CCR6 + LZ B cell subpopulation might contain B cells moving into the GC and thus increase rather than decrease their expression of CCR6. However, unlike GC B cells transitioning into MBCs, B cells entering the GC undergo rapid proliferation (Laidlaw et al., 2017) and so should exhibit a high incorporation of BrdU rather than the low levels we observed on day 9 of both endogenous (Figures 2A and 2B) and SW HEL donor (Figures 4A and 4B) GC B cell responses. To determine whether this was also true at other stages of the GC response, we gave a short 1 hr intrave- Figure S2A ) and reduced proportions of CCR6 + B cells in the LZ ( Figure S2B ), but we always found less BrdU incorporation in CCR6 + than in CCR6 À LZ B cells, even on day 7, when around half of LZ B cells expressed CCR6 ( Figure S2B ). These data indicate that CCR6 + LZ B cells overwhelmingly comprise cells exiting rather than entering the GC and, consistent with their preferential localization within the low-affinity LZ compartment, are particularly prevalent before the emergence of large numbers of highaffinity GC B cells.
CCR6 + LZlo and Some LZhi GC B Cells Transition into MBCs
Although high-affinity cells predominate within both the LZ and DZ of GCs on day 9 of the response, only $20% of IgG1 + MBCs exhibited a high affinity for HEL 3X at the same time point ( Figure 3A) . In basic terms, this observation supports our proposal that CCR6 + LZlo cells are the primary source of MBC precursors in the GC. However, the small but reproducible presence of MBCs with a high affinity for antigen lends additional weight to the suggestion that CCR6 + LZhi GC B cells make some contribution to the MBC pool.
To explore this in more detail, we compared the SHM profiles of IgG1 + MBCs and various GC subsets. Although the vast majority (90%) of SW HEL B cells sorted from the GC carried one or more somatic mutations in their IgH VDJ exon, many of the MBC clones analyzed (103/188 clones = 55%) carried no mutations whatsoever. Given that these unmutated MBCs are likely to have developed via a GC-independent pathway (Chan et al., 2009; Kaji et al., 2012; Taylor et al., 2012; Toyama et al., 2002) , we restricted our analysis to those cells that unequivocally derived from GC precursors-that is, those carrying at least one somatic mutation event. In this analysis, we focused primarily on two replacement mutations that are located within the CDR2-coding region of the IgH VDJ exon and are known to be positively selected in the SW HEL response to HEL 3X , that is, Y53D and Y58F
(which increase BCR affinity by 100-and 5-fold, respectively) (Chan et al., 2012) . Because the Y58F substitution results in only a moderate increase in antigen affinity, B cells carrying this substitution were found primarily within the LZlo and not the LZhi compartment of the GC ( Figure 4C ). Nevertheless, Y58F
+ cells were more than twice as frequent among CCR6 À than among CCR6 + LZlo B cells ( Figure 4C ), indicating that CCR6 À LZlo B cells underwent greater selection for this moderate increase in antigen affinity ( Figure 4B ). On the other hand, the prevalence of the Y58F substitution among post-GC MBCs aligned closely with that seen in CCR6 À LZlo B cells ( Figure 4C ), further supporting the proposition that the cells entering quiescence in this compartment provide the primary source of MBC precursors in the GC. In contrast to Y58F, the high-affinity Y53D substitution was found in nearly all (94%) LZhi GC B cells but was virtually absent (2%-4%) from both the CCR6 À and CCR6 + LZlo subsets (Figure 4C) . Significantly, the frequency of clones carrying the Y53D substitution among post-GC MBCs was $6-fold higher than in the CCR6 + LZlo compartment ( Figure 4C ), indicating that these particular MBCs arose from a different subset of GC B cell precursors. Because we have verified that high-affinity B cells are present in the IgG1 + MBC compartment ( Figure 3A ) and that the small CCR6 + LZhi population exhibits slow BrdU incorporation kinetics consistent with cell-cycle exit ( Figure 4A ), we suggest that CCR6 + LZhi B cells provide a small but significant contribution to the MBC pool to complement the major input from CCR6 + LZlo B cells.
To provide further evidence that CCR6 + LZ B cells do not contain a significant number of recent GC entrants, we sorted CCR6 + and CCR6 À LZ B cells at a later point in the response of SW HEL B cells to HEL 3X -SRBC (day 14). At this juncture, the proportion of CCR6 + LZ cells carrying somatic mutations in the IgH V region had increased to 97%, and the average number of SHM events per mutated clone had risen to 2.8 (Figure S2C) . Moreover, the fraction of mutated CCR6 + LZ B cells carrying the high-affinity Y53D substitution had increased to 82% on day 14 ( Figure S2C ). These data clearly indicate that CCR6 + LZ B cells must be derived from long-term GC residents that have undergone extensive SHM and affinity-based selection rather than from cells that have just recently entered the GC.
CCR6 Is Dispensable for the Development of IgG1-Switched MBCs CCR6 is required for the responsiveness of MBCs to secondary antigen challenge but not for MBC production (Elgueta et al., 2015) . We therefore reasoned that the formation of MBC precursors within the GC should be unaffected by the removal of CCR6 expression. To delete CCR6 but retain the ability to detect GC B cells activating Ccr6 transcription, we made use of the Ccr6-GFP reporter strain, in which the CCR6-coding sequence is disrupted by insertion of an eGFP cDNA (Ccr6 gfp ) (Kucharzik et al., 2002) . When B cells from control SW HEL mice carrying two wild-type copies of Ccr6 were challenged with HEL 3X -SRBCs, subsequent GC and MBC populations were negative for fluorescence in the GFP channel ( Figure 5A Figure 5D ). Rare Ccr6-GFP + cells present in the GC were largely restricted to the LZ portion of the GC (Figure 5E ), identifiable as the area distal to the T cell zone, adjacent to the follicle, and containing fewer Ki67 hi GC cells ( Figure 5D ).
Ccr6-GFP
+ LZ cells were confirmed as B cells by counterstaining for B220 ( Figure 5F ). Moreover, they were shown to be distinct from quiescent follicular B cells that might have entered the GC (Schwickert et al., 2007) . The gating strategy for these experiments is illustrated in Figure 6A ; the analysis was not restricted to B cells carrying any particular Ig isotype.
Consistent with our findings in mice, CCR6 + B cells were more frequent among LZ than among DZ B cells from human tonsillar GCs ( Figure 6A Figure 6C ). Similar, albeit non-significant, trends were observed for forward light scatter and CD38 expression ( Figure 6C ). Thus, although it was not possible to perform the more detailed cell-cycle and antigenaffinity analysis of CCR6 + GC B cells in humans, the phenotype of these cells mirrored that of the CCR6 + MBC precursors identified in mouse GCs. Our recent analysis of gene expression in SW HEL donor-derived GCs B cells (Kr€ autler et al., 2017) showed that the mouse homologs of many of the genes expressed more in human CCR6 + than in CCR6 À LZ B cells were among the genes expressed more highly in the LZlo GC B cell subset, in which CCR6 + GC cells primarily localize ( Figure 3B ), than in the LZhi subpopulation. Thus, 65% (13) were in the top 12% of the transcripts ranked in this way, and 30% (6) of them (Plac8, Slc12a6, Ccr6, Tmem66, Zmynd11, and S1pr1) were in the top 2.8% (Kr€ autler et al., 2017) . Altogether, the analysis of differentially expressed transcripts within GC and MBC subsets indicates that the CCR6 + LZ subset marks the precursors of MBCs in both human and mouse GCs. mRNA expression profiles of selected genes related to B cell activation, proliferation, migration, and differentiation are shown in Figure S3 . Unlike for the genes depicted in Figure 7 , differential expression between CCR6 + LZ B cells and either the MBC or CCR6
À LZ compartment did not reach statistical significance for most of these transcripts. Nevertheless, a general gradient of gene expression from DZ to CCR6 À LZ to CCR6 + LZ to MBC is evident in many cases, as would be expected for the phenotypic transition from GC B cell to MBC we propose here. Significantly, expression of genes active during the cell cycle, such as those encoding cyclins, cyclin-dependent kinases, cell-division-cycle proteins, and centromere proteins, was the lowest among CCR6 + LZ B cells of the GC ( Figure S3 ). Thus, like mouse CCR6 + LZ B cells, this population does not contain activated, recent GC entrants. generated fewer than 10% of the live B cell numbers after 5 days ( Figures 7C  and S4A ). Significantly, large numbers of cells exhibiting a plasma cell phenotype (CD20 lo CD38 hi CD27 hi CD138 + ) on day 5 could be generated only from cultured CCR6 + LZ B cells and MBCs ( Figure 7D ). Consistent with these observations, the secretion of antibodies, particularly class-switched isotypes (IgG and IgA), was also greatest in cultures of these two B cell subsets ( Figure 7E ). Together with the phenotypic and kinetic analyses presented in this study, this close functional relationship between CCR6 + LZ B cells and MBCs provides compelling evidence that the former population represents the GC precursors of long-lived MBCs.
DISCUSSION
The process by which MBCs differentiate from GC B cell precursors remains mostly uncharacterized, in large part because of the uncertainty surrounding the nature of the precursor B cells within the GC. The identification here of a distinct subset of GC B cells, CCR6
+ LZ B cells, as the direct precursors of GC-dependent MBCs therefore provides an important step forward in the understanding of both GC function and the molding of long-term immunity. In particular, our finding that predominantly low-affinity cells but also significant numbers of high-affinity CCR6 + LZ B cells exit the cell cycle and transition into MBCs indicates that this process is not tightly linked to antigen affinity but allows a blend of antigen affinities to contribute to the MBC pool.
Because of the well-established fragility of GC B cells ex vivo, it was not possible to show the direct transition of CCR6 + LZ B cells into MBCs either in vitro or upon in vivo transfer. However, in view of the strong links in phenotype, somatic mutation pattern, gene expression, and function between these cells, there seems to be no likely alternative explanation of the data presented here. The possibility that CCR6 + LZ B cells might represent a ''dead-end'' population is not supported by their failure to show increased levels of apoptosis or by their unique capability among LZ B cells to sustain antibody production. In addition, although phenotypic and functional similarities between CCR6 + LZ B cells and MBCs might be explained by the re-entrance of MBCs into the GC, this possibility is not consistent with our BrdU kinetic analysis, which showed that CCR6 + LZ B cells become quiescent rather than undergo rapid re-activation. Similarly, BrdU kinetics indicate that CCR6 + LZ B cells are also not recently activated naive B cells entering the GC, as does the fact that >80% of these cells carry somatic mutations in the heavy-chain variable region and so are derived from, rather than become, GC B cells.
A recent step forward in characterizing the mechanisms that drive MBC differentiation within the GC was provided by studies showing that expression of the transcription factor Bach2 is required for the production of GC-derived MBCs (Shinnakasu et al., 2016) . Given that signals from T cells reduce Bach2, the authors suggested that GC B cells that receive reduced inputs from Tfh cells are prone to increase Bach2 and thus undergo MBC differentiation. The prevalence of low-affinity GC B cells entering the MBC pool in both our study and that of Shinnakasu et al. is consistent with this model if, as has been suggested (Victora et al., 2010) , LZlo GC B cells receive less Tfh cell help than do LZhi cells. In this case, the smaller but significant contribution of CCR6 + LZhi cells to the MBC pool could be due to the limiting nature of Tfh cell help. Thus, despite having a high affinity for antigen, some LZhi cells might simply fail to encounter cognate Tfh cells and therefore undergo MBC differentiation. Because we showed that both LZlo and LZhi CCR6 + MBC precursors exit the cell cycle, we propose that a failure to receive strong stimulatory signals from Tfh cells and/or a direct encounter with antigen is a key step in MBC differentiation and explains the predominance of low-affinity specificities entering the MBC pool. The model proposed above indicates a fundamental distinction between the mechanisms driving the differentiation of MBCs and PCs from GC precursors. We have previously shown that PCs differentiate exclusively from high-affinity precursors in the GC and recently demonstrated that this process initiates among a subset of LZhi cells (Kr€ autler et al., 2017) . Thus, there appears to be a symmetry to the differentiation of the key effector populations that emerge from the GC, such that PCs derive from LZhi precursors and MBCs primarily from the LZlo compartment. This dichotomy stems in part from the fact that the initiation of PC differentiation is tightly linked to antigen affinity through its requirement for a positive signal delivered upon direct contact with antigen (Kr€ autler et al., 2017) . As discussed above, MBC differentiation appears instead to be associated with a paucity of extracellular inputs and so is more prevalent for (but not exclusive to) LZlo B cells. Why CCR6
+ LZ B cells differentiate into MBCs under such circumstances instead of undergoing apoptosis and ingestion by tingible body macrophages will be an important question to answer in future studies. Although CCR6 expression clearly identifies MBC precursors within the GC, we found that the expression of this chemokine receptor by responding B cells was not required for MBC differentiation and had no detectable impact on the GC subsets analyzed in this study. Although this is in agreement with studies of mice challenged with phycoerythrin (Elgueta et al., 2015) , other studies employing the NP-KLH immunogen have noted some increase in GC size (Wiede et al., 2013) and a shift in the LZ/DZ ratio (Reimer et al., 2017) in CCR6-deficient mice, potentially linked to CCR6 function early in the response. Although these effects could also be due to CCR6 functions in non-B cells or subtle differences associated with different immunization strategies, all of these studies are consistent in showing that CCR6 is not required for MBC development despite the important role it does play in MBC positioning and subsequent function during recall responses (Elgueta et al., 2015) .
The mRNA microarray data derived from human tonsillar B cell populations provide strong evidence that CCR6 + LZ B cells form the precursors for MBCs in both human and mouse GCs. In addition, the specific transcripts differentially regulated during the process of MBC differentiation could provide insights into MBC differentiation and function. CCR6 + MBC precursors in the LZ were found to increase S1PR1 and decrease S1PR2, potentially facilitating egress from the GC (Green and Cyster, 2012) . Similarly, EBI2 (GPR183) was increased, consistent with surface expression of EBI2 in our murine experiments, which could facilitate migration of MBCs toward the outer follicle . The expression of S1PR1, EBI2, and CCR6 therefore follows a similar pattern: undergoing marked reduction upon GC B cell differentiation and a subsequent increase upon commitment to MBC differentiation. Because the loss of S1PR1 and EBI2 expression on GC B cells is due to direct BCL6-mediated suppression of S1pr1 and Gpr183 (Huang et al., 2014) and Ccr6 possesses a functional BCL6-binding site (Hatzi et al., 2015) , it is likely that the coordinated repression of these homing receptor genes in GC B cells and their subsequent re-expression upon MBC differentiation are attributable to the enforcement and subsequent release of BCL6-mediated transcriptional repression, respectively. This scenario is consistent with the concept that MBC differentiation in the GC is associated with reduced antigen and/or Tfh cell inputs, leading to the loss of the GC B cell transcriptional signature largely through the activity of BCL6. Unlike plasma cell differentiation, however, loss of BCL6 during MBC differentiation is not accompanied by the induction of IRF4 and BLIMP1 because it requires engagement of high-affinity antigen by the BCR (Kr€ autler et al., 2017) . Two recent studies used specialized reporter mice to identify GC B cells with either decreased expression of S1pr2 (Laidlaw et al., 2017) or cell-cycle quiescence (Wang et al., 2017) . Because the cells identified in each of these studies were also enriched with Ccr6 transcripts (Laidlaw et al., 2017; Wang et al., 2017) , it is likely that they are closely related to the LZ-resident MBC precursors that we report here. Nevertheless, the ability to utilize surface staining for CCR6 provides a unique and universal method for identifying MBC precursors in both mice and humans without the requirement of specialized reporter systems. In this regard, it is important to emphasize that a definitive GC B cell gate (such as those described in this study) is required in conjunction with CCR6 detection to ensure that cells that have already undergone full MBC differentiation are excluded from any population defined as MBC precursors by flow cytometry. For instance, the mouse MBC precursors recently identified by Wang et al. (2017) expressed high levels of CD38 but would have been mostly excluded by the flow-cytometric gates used in our study. Determining how much CD38 is in fact expressed on MBC precursors within mouse GCs will ultimately require coupled photo-conversion and flow-cytometry studies, but it is reasonable to postulate that the CCR6 + CD38
lo LZ B cells we have described are the earliest cells identifiably committed to MBC differentiation within mouse GCs. Similarly, the human GC B cell gates employed in our study also enabled the identification of CCR6 + LZ cells that had only recently committed to MBC differentiation, as evidenced by the fact that they retained expression of BCL6 mRNA. The identification of CCR6 + B cells within the LZ as direct progenitors of MBCs provides a new window into the evolution of immune responses. In practical terms, flow-cytometric detection of CCR6 + GC B cells could provide a means of rapidly assessing vaccine efficacy when applied to fine needle aspirates or core biopsies from local lymph nodes in vaccinated subjects and could provide an additional means of investigating patients with primary immuno-deficiencies. More fundamentally, the finding that both high-and low-affinity GC B cells contribute to the MBC pool suggests the evolution of basis for both eliciting rapid recall responses against the original infectious agent (via high-affinity MBCs) and providing broader coverage against related or mutated pathogens (via low-affinity MBCs).
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Single Cell Sorting and SHM Analysis For SHM analysis of individual SW HEL B cells, splenocytes were stained and single clones were sorted into plates on a FACSAria III cell sorter (BD). The variable region of the HyHEL10 heavy chain gene was amplified by PCR and sequenced as previously described . Clonal sequences were processed using the Biostrings Bioconductor package in the R environment (http://www. bioconductor.org/packages/release/bioc/html/Biostrings.html). Each clone was aligned against the HyHEL10 wild-type sequence using the pairwise Alignment function, with type = ''local-global.'' Alignments scoring below 400 and those containing insertions or deletions were filtered out as failing quality control. Successful clonal sequences were then computationally translated into amino acid sequences using the Standard Genetic Code (http://www.ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi#SG1). In addition, individual chromatograms of all clones were checked manually for quality control purposes.
Fluorescence Microscopy
Ccr6 gfp/gfp mice and wild-type controls were immunised with 2 3 10 8 SRBCs, spleens harvested on day 9 and fixed in 10% formaldehyde (Sigma) for 24 hr. 7 mm cryosections were mounted onto Superfrost Plus slides (Menzen-Glaser) and fixed with cold acetone. Slides were blocked with 30% horse serum (Life Technologies) and then stained with fluorochrome-conjugated antibodies as outlined in the Key Resources Table. Four-color images were acquired on a Leica DM5500 and analyzed using Photoshop CS5 Version 12.1 (Adobe).
Tonsil Microarray
Single cell suspensions of tonsil samples were prepared, stained with antibodies and sorted on a FACSAria III cell sorter (BD) into TRIzol (Invitrogen). RNA extraction was performed using chloroform, isopropanol precipitation followed by washing with 70% ethanol. RNA microarray was performed at the Ramaciotti Centre (UNSW) using the Human Gene 2.0 ST Array (Affymetrix). Array analysis was conducted using bio-conductor packages from R. CEL-files, read and normalized using the oligo package251, and limma252 was used to call differential expression between the samples using a cutoff of logFC > 1 and a Benjamini-Hochberg adjusted p value of either <0.05 or <0.01. The array data are available at ArrayExpress: E-MTAB-3974.
In Vitro Tonsil B Cell Cultures Single cell suspensions of tonsil samples were stained with antibodies and sorted as above. Equal numbers of each B cell subpopulation were cultured with IL-21 (50 ng/mL, Peprotech) and human CD40L (200 ng/mL, R&D Systems) at 37 C with 5% CO 2 for 5 days. Cells were pelleted and the supernatants removed. Cells were stained with antibodies, dead cells were excluded using the Zombie Aqua Fixable Viability Kit (Biolegend) and analyzed by flow cytometry as above. 20,000 CaliBRITE beads (BD) were added to each well prior to acquisition to facilitate calculation of cell numbers in each well.
Human Immunoglobulin Quantitation by ELISA Microtiter plates (Thermo Fisher) were pre-coated with goat anti-human IgM, IgG, or IgA polyclonal antisera (Southern Biotechnology) and blocked with 2% fetal calf serum in PBS. Culture supernatants and Ig standards (Sigma-Aldrich) were added to the wells and incubated for 2 hr at 37 C before the addition of biotinylated anti-human IgM, IgG, or IgA antisera (Southern Biotechnology). Bound Ab was detected by the addition of streptavidin-conjugated HRP (Jackson Immunoresearch Labs) and visualized with ABTS (Sigma-Aldrich: 1 mg/mL) prepared in citrate buffer (pH 4.5) containing 0.03% H 2 O 2 .
QUANTIFICATION AND STATISTICAL ANALYSIS Statistical Analysis
Statistical parameters including the description each data point (n value), the number of mice or tonsils per experiment, the number of replicates, the meaning of bars and the statistical tests used are contained in the figure legends. Statistical were calculated using Prism 6.0 software (GraphPad). For comparisons between two normally distributed groups a two-tailed unpaired t test with Welch's correction was used. For comparison between more than two groups statistical analysis was performed using a one-way ANOVA with the post hoc Bonferroni test. In the figures, non-significant p values R 0.05 are indicated by ''ns,'' while asterisks stand for *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Quantitation of CCR6-GFP + Cells by Histology
To estimate the number of GFP + B cells in the follicle (Figure 5G ), the follicle was divided into eight sectors, the number of GFP + cells in that sector counted, and then multiplied by eight.
DATA AND SOFTWARE AVAILABILITY
The accession number for the human tonsil microarray data reported in this article is ArrayExpress: E-MTAB-3974 (https://www.ebi. ac.uk/arrayexpress/experiments/E-MTAB-3974/).
